Objectives: To determine the ef®cacy of oral iodized oil in goitrous children who are both selenium (Se) and iodine de®cient; to investigate if Se status modi®es the response of iodine de®cient, goitrous children to oral supplementation with iodized oil. Design: A longitudinal intervention trial. Setting: Two rural villages in the western Co Ãte d'Ivoire. Subjects: 51 goitrous non-anemic schoolchildren with both iodine and Se de®ciency. Intervention: Each child received an oral dose of 0.4 ml iodized poppyseed oil containing 200 mg of iodine. They were followed for 1 y with measurements of urinary iodine (UI), thyrotropin (TSH), thyroxine (T4), and thyroid volume by ultrasound. Results: At baseline all children were goitrous and Se de®cient; median UI was 29 mgal and mean serum Se (s.d.) was 14.8 (10.7) mgal. After receiving iodized oil, thyroid volume decreased signi®cantly vs baseline at 10, 15, 30 and 50 weeks (P`0.001). At 50 weeks mean percentage change in thyroid volume from baseline was746.6% and only ®ve children remained goitrous. Median TSH values at 5, 10, 15, 30 and 50 weeks were reduced signi®cantly (P`0.001) compared to baseline. Among individual children the severity of Se de®ciency predicted the degree of response to iodized oil. Baseline serum Se and percentage change in thyroid volume from baseline at 50 weeks were strongly correlated (r 2 0.554). Baseline Se and percentage decrease in TSH from baseline at 30 weeks were also well-correlated (r 2 0.467). Conclusion: Although more severe Se de®ciency partially blunts the thyroid response to iodine supplementation, oral iodized oil is an effective method for iodine repletion in goitrous children who are Se de®cient.